Company Filing History:
Years Active: 2023
Title: The Innovations of Andrew Geall
Introduction
Andrew Geall is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of molecular virology, particularly in the prevention and treatment of rabies virus infection. His innovative work has the potential to impact public health positively.
Latest Patents
Andrew Geall holds a patent for "Compositions and methods for the prevention and treatment of rabies virus infection." This patent relates to nucleic acid molecules encoding a modified alphavirus viral genome or self-replicating RNA (srRNA) construct. It also includes recombinant cells and pharmaceutical compositions that utilize these nucleic acid molecules. The methods described in the patent aim to elicit an immune response in subjects and provide strategies for preventing and treating rabies virus infection. He has 1 patent to his name.
Career Highlights
Geall is currently associated with Replicate Bioscience, Inc., where he continues to advance his research and development efforts. His work is at the forefront of virology, focusing on innovative solutions to combat viral infections.
Collaborations
Andrew Geall collaborates with notable colleagues, including Nathaniel Stephen Wang and Shigeki Joseph Miyake-Stoner. Their combined expertise enhances the research and development initiatives at Replicate Bioscience, Inc.
Conclusion
Andrew Geall's contributions to the field of molecular virology, particularly through his patent on rabies virus treatment, highlight his role as an innovative inventor. His work continues to pave the way for advancements in public health and virology.